cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Adc Therapeutics Sa
5 own
4 watching
Current Price
$2.69
$0.04
(1.51%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
66.13M
52-Week High
52-Week High
6.04000
52-Week Low
52-Week Low
0.35991
Average Volume
Average Volume
0.37M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization66.13M
icon52-Week High6.04000
icon52-Week Low0.35991
iconAverage Volume0.37M
iconDividend Yield--
iconP/E Ratio--
What does the Adc Therapeutics Sa do?
ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma; Phase III clinical trial in combination with rituximab to treat relapsed or refractory DLBCL in second-line transplant-ineligible patients; and Phase I clinical trial for treatment of relapsed or refractory non-hodgkin lymphoma (NHL). The company is also developing camidanlumab tesirine, an ADC that has completed Phase I clinical trial to treat relapsed or refractory NHL; in Phase II clinical trial in relapsed or refractory hodgkin lymphoma; and in Phase Ib clinical trial for selected advanced solid tumors. In addition, it develops ADCT-602, which is in Phase Ia clinical trial for treatment of acute lymphoblastic leukemia; ADCT-601 and ADCT-901 that are in Phase Ia clinical trial for treatment of various solid tumors; and preclinical product candidates, including ADCT-701 and ADCT-901 for the treatment of solid tumors. It has a collaboration and license agreement with Genmab A/S, Bergenbio AS, Synaffix B.V., Mitsubishi Tanabe Pharma Corporation, Overland Pharmaceuticals, and MedImmune Limited. ADC Therapeutics SA was incorporated in 2011 and is headquartered in Epalinges, Switzerland.
Read More
News & Events about Adc Therapeutics Sa.
Globe Newswire
1 year ago
Data being presented at the EHA 2023 Hybrid Congress will also be highlighted in an encore oral presentation at 17-ICMLLAUSANNE, Switzerland, June 09, 2023 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced updated results from LOTIS-2, the pivotal Phase 2 clinical trial of ...
PR Newswire
1 year ago
PharmaVentures establishes an office in Seoul to enhance access for South Korean biotechs PharmaVentures establishes an office in Seoul to enhance access for South Korean biotechs PR Newswire LONDON, March 29, 2023 LONDON, March 29, 2023 /PRNewswire/ -- PharmaVentures announces its new office in...
Zolmax
1 year ago
Shares of ADC Therapeutics SA (NYSE:ADCT Get Rating) have earned a consensus rating of Moderate Buy from the six ratings firms that are presently covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to ...
Ticker Report
1 year ago
ADC Therapeutics SA (NYSE:ADCT Get Rating) Analysts at Capital One Financial issued their FY2027 earnings per share (EPS) estimates for shares of ADC Therapeutics in a research report issued to clients and investors on Wednesday, March 1st. Capital One Financial analyst N. Quibria ...
Frequently Asked Questions
Frequently Asked Questions
What is Adc Therapeutics Sa share price today?
plus_minus_icon
Can Indians buy Adc Therapeutics Sa shares?
plus_minus_icon
How can I buy Adc Therapeutics Sa shares from India?
plus_minus_icon
Can Fractional shares of Adc Therapeutics Sa be purchased?
plus_minus_icon
What are the documents required to start investing in Adc Therapeutics Sa stocks?
plus_minus_icon
What is today’s traded volume of Adc Therapeutics Sa?
plus_minus_icon
What is today’s market capitalisation of Adc Therapeutics Sa?
plus_minus_icon
What is the 52-Week High and Low Range of Adc Therapeutics Sa?
plus_minus_icon
What percentage is Adc Therapeutics Sa down from its 52-Week High?
plus_minus_icon
What percentage is Adc Therapeutics Sa up from its 52-Week Low?
plus_minus_icon
Current Price
$2.69
$0.04
(1.51%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00